As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
How you can devise a cancer prevention action plan.
How to love yourself — and your selfies — without filters or fillers.
Pre-Menopausal Heavy Uterine Bleeding and Uterine Fibroids Study
Clinical Trial Title:
Study for pre-menopausal women with heavy uterine bleeding and uterine fibroids
Clinical Trial Protocol ID:
11081503
Clinical Trial Investigator Name:
Barbara Soltes, MD
Clinical Trial Protocol Description:
The purpose of this study is to determine the efficacy of an oral investigational medication to decrease frequency and amount of uterine bleeding as well as size or volume of uterine fibroids.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have a diagnosis of uterine fibroids.
- Have heavy uterine bleeding during menstrual cycles.
- Are a pre-menopausal women 20 years of age or older.
You will be excluded from the study if any of the following criteria apply to you:
- Have endometriosis.
- Have osteoporosis.
- Are currently using any corticosteroid.
This is a partial list of eligibility requirements.
Clinical Trial Area:
Women's Health
Contact Phone:
(312) 563-2611
Contact Name:
Carol Miller